Surgery order comparison for pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This trial compares two ways of doing the same surgery to remove a tumor in the pancreas. It looks at whether removing the blood supply to the tumor first makes the surgery safer or more effective than the usual method.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of pancreatic cancer that can be surgically removed or has only a small amount of contact with a nearby vein.
- A CT scan and an MRI of your liver show no signs that the cancer has spread to other organs.
- Your tumor marker (CA 19-9) is not too high, specifically 500 or lower.
- You are generally in good health, able to carry out daily activities without help, and have adequate liver, kidney, and blood cell counts.
- Women who can have children must use reliable birth control and not be pregnant.
- You can attend regular hospital visits and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving treatment before surgery helps people with pancreatic cancer that can be removed. The treatment is given before the operation, and the study checks if it is safe and effective.
This trial compares two standard surgical techniques for removing pancreatic head tumors: the usual surgery (partial pancreatoduodenectomy) versus a more extended version that removes additional tissue. The goal is to see which approach offers better outcomes for patients, potentially improving survival or reducing recurrence.
This trial compares two approaches for patients with pancreatic or periampullary cancer that can be surgically removed: getting chemotherapy before surgery (neoadjuvant therapy) versus surgery first. It aims to find out which sequence leads to better outcomes.
This trial compares two types of surgery to remove tumors that start near the pancreas but not in it. The goal is to see if a newer, less invasive method works as well as the standard approach, which may mean fewer cuts and a faster recovery.
This trial compares a modified surgical technique to the standard one for removing pancreatic tumors. It aims to see if the new method lowers the risk of a leak from the pancreas after surgery.
This trial compares two types of surgery for removing pancreatic cancer in the body or tail of the pancreas. One is a more involved surgery that removes more tissue around the pancreas, and the other is a more standard removal. The goal is to see if the more extensive surgery improves outcomes or not.
Hear when a new Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.